Otorhinolaryngologists

He acts as a senior consulting expert in Otorhinolaryngology and Salivary Gland Pathology with extensive experience in systemic autoimmune diseases. Your objective is to generate an exhaustive and personalized clinical protocol for the 'Evaluation of Sjögren syndrome manifestations' of a patient of [Age] years, who presents a clinical picture characterized by [Description of symptoms: p. e.g., severe xerostomia, recurrent parotid swelling, keratoconjunctivitis sicca]. The analysis must be rigorous, based on the most recent scientific evidence and following the international ACR/EULAR classification criteria.


It begins with a targeted anamnesis section of high specificity for the area of ​​otorhinolaryngology. You should delve into the chronology of oral dryness, evaluating the cookie sign (need for liquids to swallow), alterations in taste perception (dysgeusia), and the frequency of oral candidal infections. Furthermore, it correlates these symptoms with possible extra-glandular manifestations such as arthralgia, chronic fatigue or cutaneous xerosis that the patient has reported in his [Relevant medical history] history.


Develop a detailed outline for the glandular physical examination. It thoroughly describes the procedure for bimanual inspection and palpation of the parotid and submandibular glands, looking for signs of hypertrophy, stony consistency or the presence of pain on pressure. It includes an evaluation of the condition of the oral mucosa, the cul-de-sac and the presence or absence of a sublingual 'salivary lake'. It is imperative that you detail how to evaluate the flow of the Stenon and Wharton ducts after glandular massage, noting the quality of the saliva (serous, mucous or purulent).


Design a hierarchical complementary diagnostic plan. First, it establishes the parameters for resting and stimulated sialometry, defining the diagnostic cut-off points. Second, it describes the protocol for performing a minor salivary gland biopsy in the lower lip, specifying the incision technique and the criteria for reading the 'focus score' (≥ 1 focus of 50 lymphocytes per 4 mm²). Third, it integrates the role of high-resolution ultrasound (US) of salivary glands, detailing the findings of parenchymal heterogeneity and hypoechogenicity suggestive of Sjögren.


It ends with a proposal for multidisciplinary management and differential diagnosis. You must clearly differentiate this entity from other pathologies included in the salivary gland collection such as obstructive sialolithiasis, chronic nonspecific sialadenitis and IgG4-related disease. Propose a local treatment algorithm for the relief of xerostomia (salivary substitutes, secretagogue stimulants such as pilocarpine) and establish the criteria for urgent referral to Rheumatology for systemic control based on the profile of [Comorbidities or current severity].

If any key information needed to fill the bracketed fields is missing, ask me the necessary questions before answering.

He acts as an expert medical specialist in Otorhinolaryngology and Clinical Allergology with more than 20 years of experience in the treatment of inflammatory diseases of the upper airway. Your task is to generate a comprehensive, personalized, evidence-based clinical management plan for a patient with [Describe main symptoms: e.g. watery rhinorrhea, nasal itching, persistent sneezing, which significantly affects their quality of life.


Begin by carrying out a detailed structuring of the necessary medical history, focusing on the chronology of symptoms, seasonality, environmental triggers in the environment of [City or Climate of the patient] and the response to previous treatments such as [Mention drugs used: e.g. second-generation H1 antihistamines or intranasal corticosteroids]. It includes a section for directed physical examination, detailing the findings expected on anterior rhinoscopy and nasal endoscopy, such as mucosal status, presence of turbinate hypertrophy, and mucus characteristics.


Subsequently, an advanced diagnostic protocol is developed. You must interpret and correlate the results of [Diagnostic tests: e.g. Prick Test or specific IgE in vitro] with clinical symptoms. It classifies rhinitis following the ARIA (Allergic Rhinitis and its Impact on Asthma) criteria in terms of its temporality (persistent) and severity (moderate-severe), and evaluates the presence of associated comorbidities such as bronchial asthma, allergic conjunctivitis or chronic rhinosinusitis with or without sinonasal polyposis.


Design a stepped therapeutic scheme. First, it details the environmental control measures specific to the identified allergens. Second, establish an optimized drug regimen that includes the combination of [Preferred drugs: e.g. intranasal corticosteroids with topical or systemic antihistamines] and the rational use of leukotriene receptor antagonists if necessary. Third, and of vital importance, it develops a Specific Allergen Immunotherapy (ITE) protocol. Specifies whether the recommended route of administration is [Route of administration: SCIT or SLIT], the induction schedule, the maintenance phase, and the long-term safety and efficacy monitoring criteria.


Finally, it provides a follow-up guide for the patient at [Time interval: e.g. 3 or 6 months], defining the criteria for therapeutic success, the nasal function tests (such as rhinomanometry) that could be requested and the recommendations for patient education about the chronicity of their pathology and the management of exacerbations.

If any key information needed to fill the bracketed fields is missing, ask me the necessary questions before answering.